title: Trial tests new combination of drugs to treat tuberculosis.
authors.forename: Bob
authors.initials: B
authors.lastname: Roehr
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001372:Aza Compounds / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009593:Nitroimidazoles / Q000008:administration & dosage; D011718:Pyrazinamide / Q000008:administration & dosage; D011804:Quinolines / Q000008:administration & dosage; D012109:Research Support as Topic; D014376:Tuberculosis / Q000188:drug therapy* / Q000191:economics; D014481:United States
chemical_list: D000995:Antitubercular Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D009593:Nitroimidazoles; D011804:Quinolines; C410767:pretomanid; D011718:Pyrazinamide; D000077266:Moxifloxacin